References
- Rowley J. D. A new consistent abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and giemsa staining. Nature 1973; 243: 290–293
- Shtivelman E., Lifshitz B., Gale R. P., Canaani E. Fused transcripts of abl and bcr genes in chronic myelogenous leukaemia. Nature 1985; 315: 550–554
- Krontiris T. G., Cooper G. M. Transforming activity of human tumor DNAs. Proc. Natl. Acad. Sci. USA 1981; 78: 1181–1184
- Hirai H., Tanaka S., Azuma M., Anraku Y., Kobayashi Y., Fujisawa M., Okabe T., Urabe A., Takaku F. Transforming genes in human leukemia cells. Blood 1985; 66: 1371–1378
- Liu E., Hjelle B., Bishop J. M. Transforming genes in chronic myelogenous leukemia. Proc. Natl. Acad. Sci. USA 1988; 85: 1952–1956
- Janssen J. W. G., Steenvoorden A. C. M., Lyons J., Anger B., Bohlke J. U., Bos J. L., Seliger H., Bartram C. R. RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders and myelodys-plastic syndromes. Proc. Natl. Acad. Sci. USA 1987; 84: 9228–9232
- Collins S. J., Howard M., Andrews D. F., Agura E., Radich J. Rare occurrence of N-ras point mutations in Philadelphia chromosome positive chronic myeloid leukemia. Blood 1989; 73: 1028–1032
- Daley G. Q., McLaughlin J., Witte O. N., Baltimore D. The CML-specific P210 bcr/abl protein, unlike v-abl does not transform N1H3T3 fibroblasts. Science 1987; 237: 532–535
- Ben-Neriah Y., Daley G. Q., Mes-Masson A. M., Witte O. N., Baltimore D. The chronic myelogenous leukemia specific P210 protein is the product of the bcr/abl hybrid gene. Science 1986; 233: 212–214
- Daley G. Q., Van Etten R. A., Baltimore D. Induction of chronic myelogenous leukemia in mice by the P210ber/abl gene of the Philadelphia chromosome. Science 1990; 247: 824–830
- Copeland N. G., Cooper G. M. Transfection by exogenous and endogenous murine retrovirus DNAs. Cell 1979; 16: 347–356
- Fasano O., Birnbaum D., Edlund L., Fogh J., Wigler M. New human transforming genes detected by a tumorigenicity assay. Mol. Cell. Biol 1984; 4: 1695–1705
- Inokuchi K., Komiya I., Dan K., Kuriya S., Shinohara T., Nomura T. TdT-positive, Smlg-negative B precursor cell leukemia with Burkitt morphology: a case report. Leukemia and Lymphoma 1990; 2: 251–255
- Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294–5299
- Roth M. S., Antin J. H., Bingham E. L., Ginsburg D. Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia. Blood 1989; 74: 882–885
- Jackson P., Baltimore D. N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl. The EMBO Journal 1989; 8: 449–456
- McLaughlin J., Chianese E., Witte O. N. In vitro transformation of immature hematopoietic cells by the P210 BCR-ABL oncogene product of the Philadelphia chromosome. Proc. Natl. Acad. Sci. USA 1987; 84: 6558–6562
- Daley G. Q., Baltimore D. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein. Proc. Natl. Acad. Sci. USA 1988; 85: 9312–9316
- Lugo T. G., Witte O. N. The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc. Mol. Cell. Biol 1989; 9: 1263–1270
- Shore S. K., Bogart S. L., Reddy E. P. Activation of murine c-abl protooncogene: Effect of a point mutation on oncogenic activation. Proc. Natl. Acad. Sci. USA 1990; 87: 6502–6506